TP53 and female reproductive organ cancer: P53 inactivation is associated with an increase of the mitochondrial BCL-2, an anti-apoptotic protein, and it has been demonstrated that upregulation of BCL-2 was responsible for the acquired chemoresistance to platinum compounds in gynecological cancers [168, 169].